Data as of Dec 06
| -0.46 / -0.16%|
The 20 analysts offering 12-month price forecasts for Regeneron Pharmaceuticals Inc have a median target of 339.50, with a high estimate of 376.00 and a low estimate of 225.00. The median estimate represents a +20.07% increase from the last price of 282.74.
The current consensus among 22 polled investment analysts is to Buy stock in Regeneron Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.